# SUNPHARMA OVERVIEW
forum
SUNPHARMA Share Price Discussion
Sun Pharmaceutical Industries Ltd.
Sector: Pharmaceuticals and health care
Sector: Pharmaceuticals and health care
SUNPHARMA Share Price *
413.1 -3.9 (-0.94%)
* (quote may be delayed)
SUNPHARMA Discussion Forum
Sell sunpharma blw 410 for 408 406 404
Sl 4 points
Like
reply
Reply (1)
share
Share
Latest replies
Low made 408.25
Q. Sunpharma views
Like
reply
Reply (1)
share
Share
Latest replies
CHART IS WEEK..ONLY DRIVEN BU CHINA NEWS
Any suggestions for sunpharma?
Like
reply
Reply
share
Share
Buy Sunpharma 420 CE @ 8.2-8.3 Target 10/12+ SL 7 Below
Like
reply
Reply (1)
share
Share
Latest replies
Futures 419.3
PROFIT OF 3300/-
🔥🔥🔥🔥🔥🔥🔥
Options 9.25
PROFIT OF 1100/-
**OPTION CALL**
**********************
**STOCK**: SUNPHARMA 420 PE @ 9.75
**STOP LOSS:** YOURS
**TARGET:** 12.75
**LOT SIZE:** 1100
Like
reply
Reply (4)
share
Share
Latest replies
10.60
11.00
11.05
12.30
These 12 Nifty stocks trading at discount to 5-yr avg P/E; time to buy?
The golden rule of investment is to pour money in stocks that are trading at attractive levels compared to their intrinsic value, thus allowing investors to create wealth over a period of time
The golden rule of investment is to pour money in stocks that are trading at attractive levels compared to their intrinsic value, thus allowing investors to create wealth over a period of time
Moneycontrol
Like
reply
Reply
share
Share
link
https://twitter.com/CNBCTV18Live/status/1163995658233102336/photo/1
t
Along with Taro's approval, @SunPharma_Live also receives @US_FDA nod for Pantoprazole Sodium Injectable, used to treat stomach ulcers & other gastro issues https://t.co/Kj7miPnNGO
Like
reply
Reply
share
Share
Q. I bought 500 ce at 3.60 rs 2 lots sept expiry... Is it worth?
1
reply
Reply (6)
share
Share
Latest replies
15 ??
Mean
Exit as soon as possible on bounce
Unless you know of any inside trade, I'd say get out of it. If you do know of any insider trade do let us know as well :)
@safe agree.
An evening walk down D-St: Sensex, Nifty erase most gains to end marginally higher
BSE Midcap and Smallcap indices outperformed benchmark Sensex, logging gains of 0.20 percent and 0.51 percent, respectively
BSE Midcap and Smallcap indices outperformed benchmark Sensex, logging gains of 0.20 percent and 0.51 percent, respectively
Moneycontrol
1
reply
Reply
share
Share
Buy these 15 handpicked stocks for 11-44% return in next one year
Umesh Mehta, Head of Research, Samco Securities said the first year of any government is generally turbulent and it may not really cheer the stock market
Umesh Mehta, Head of Research, Samco Securities said the first year of any government is generally turbulent and it may not really cheer the stock market
Moneycontrol
Like
reply
Reply
share
Share
rajiv kumar jha in SUNPHARMASun pharma buy@405/408 Sl 397 q-200/300
Not activate
Like
reply
Reply
share
Share
Buy sunpharma 500 ce @ 4.5 - 5
Sept exp
And hold for few days
Like
reply
Reply
share
Share
Sun Pharma और China Medical System के बीच करार हुआ है जिसके तहत China Medical चीन में 7 जेनरिक प्रोडक्ट डेवलप करेगी।
Like
reply
Reply
share
Share
Sun Pharma climbs 5% after USFDA classifies Halol plant as 'No Action Indicated'
Halol is a crucial facility for Sun Pharma as it contributes around 15 percent of total US sales.
Halol is a crucial facility for Sun Pharma as it contributes around 15 percent of total US sales.
Moneycontrol
Like
reply
Reply
share
Share
AncientStock in SUNPHARMA✅ Buy SUNPHARMA 424.50 2Lots
✅ SUNPHARMA 431.80 High , 1️⃣6️⃣0️⃣0️⃣0️⃣ Profits 🔥🔥🔥
Like
reply
Reply
share
Share
✅ Buy SUNPHARMA 424.50 2Lots
1
reply
Reply
share
Share
levels in sun pharma
Level 1 - buy abv 425 for 427 429 430
Level 2 - sell blw 418 for 416 414 412
sl 4 points in both
2
reply
Reply (1)
share
Share
Latest replies
All trgt achieved 👍👍👍
High made 431.80
7480 profit
Small Traders can book profit or shift sl
Sun pharma buy@405/408
Sl 397 q-200/300
Like
reply
Reply
share
Share
*Futures & Options educational trades for the week 19.8.19 to 23.8.19*
The below trades are given for *educational* purposes and i am not responsible for any losses or profits.
Please note (a) best entry is taken on day 1 (b) the high/low achievement of the week is taken for calc...
Read more...
Like
reply
Reply
share
Share
Trade Setup for Monday: Top 15 things to know before Opening Bell
Rajesh Palviya of Axis Securities expects Nifty to trade in the range of 11,250-10,900 with a positive bias in coming week
Rajesh Palviya of Axis Securities expects Nifty to trade in the range of 11,250-10,900 with a positive bias in coming week
Moneycontrol
Like
reply
Reply
share
Share
Sun Pharma enters pact with China Medical Systems to commercialise 7 generic products
The total addressable market size for all these eight products is about $1 billion (as per recent IQVIA data) in Mainland China.
The total addressable market size for all these eight products is about $1 billion (as per recent IQVIA data) in Mainland China.
moneycontrol.com
Like
reply
Reply
share
Share
Hold Sun Pharmaceutical Industries; target of Rs 470: ICICI Direct
ICICI Direct recommended hold rating on Sun Pharmaceutical Industries with a target price of Rs 470 in its research report dated August 14, 2019.
ICICI Direct recommended hold rating on Sun Pharmaceutical Industries with a target price of Rs 470 in its research report dated August 14, 2019.
moneycontrol.com
Like
reply
Reply
share
Share
BUY SUN PHARMA GUT 412 SL 411 TGT 415/420/429/439
Like
reply
Reply (2)
share
Share
Latest replies
Are you sure for intraday?
INTRADAY TRADER BOOK AT FIRST TARGET , POSITIONAL HOLD WITH SL
Chart Check: Where are Sun Pharma, Glenmark headed after a 5-10% fall in two days?
Sun Pharma which reported healthy numbers in June quarter failed to hold onto gains and lost momentum largely due to growing concerns in US and management rejig
Sun Pharma which reported healthy numbers in June quarter failed to hold onto gains and lost momentum largely due to growing concerns in US and management rejig
moneycontrol.com
Like
reply
Reply
share
Share
Chart Check: Where is Sun Pharma, Glenmark headed after 5-10% fall in two days?
Sun Pharma which reported healthy numbers in June quarter failed to hold onto gains and lost momentum largely due to growing concerns in US and management rejig
Sun Pharma which reported healthy numbers in June quarter failed to hold onto gains and lost momentum largely due to growing concerns in US and management rejig
moneycontrol.com
Like
reply
Reply
share
Share
Chart Check: Where is Sun Pharma, Glenmark headed after Wednesday’s 4-8% fall?
Sun Pharma which reported healthy numbers in June quarter failed to hold onto gains and lost momentum largely due to growing concerns in US and management rejig
Sun Pharma which reported healthy numbers in June quarter failed to hold onto gains and lost momentum largely due to growing concerns in US and management rejig
www.moneycontrol.com
Like
reply
Reply
share
Share
Sell blw 407 for 405 403 401
Sl 4 points
Like
reply
Reply
share
Share
SUNPHARMA NOW 404 IS STRONG SUPPORT AND 431 IS STRONG RESISTANCE......
IF ANY SIDE BREAK LOWER OR UPER ADDITIONAL 5% MOVE POSSIBLE 💎🙏
Like
reply
Reply
share
Share
Pick these 5 stocks for 22-38% returns by next Independence Day
Historically, the midcap and smallcap index haven’t given negative returns for two consecutive years, hence there is a good chance of a recovery from here on
Historically, the midcap and smallcap index haven’t given negative returns for two consecutive years, hence there is a good chance of a recovery from here on
www.moneycontrol.com
1
reply
Reply
share
Share
MFs flocked to IndusInd, Kotak Mahindra Bank and Infosys in July
The weight of ‘defensives’ in the mutual funds portfolio rose 170 basis points in the month to 28.9 percent.
The weight of ‘defensives’ in the mutual funds portfolio rose 170 basis points in the month to 28.9 percent.
www.moneycontrol.com
Like
reply
Reply
share
Share
An evening walk down Dalal Street: Delayed US tariffs lift market sentiments
The breadth of the market also improved as 1,319 stocks logged gains against 1,156 that suffered losses. As many as 140 stocks remained unchanged
The breadth of the market also improved as 1,319 stocks logged gains against 1,156 that suffered losses. As many as 140 stocks remained unchanged
moneycontrol.com
Like
reply
Reply
share
Share
Buy Sun Pharma; target of Rs 545: HDFC Securities
HDFC Securities is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 545 in its research report dated August 14, 2019.
HDFC Securities is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 545 in its research report dated August 14, 2019.
moneycontrol.com
Like
reply
Reply
share
Share
Hold Sun Pharmaceutical Industries; target of Rs 500: Sharekhan
Sharekhan recommended Hold rating on Sun Pharmaceutical Industries with a target price of Rs 500 in its research report dated August 13, 2019.
Sharekhan recommended Hold rating on Sun Pharmaceutical Industries with a target price of Rs 500 in its research report dated August 13, 2019.
moneycontrol.com
Like
reply
Reply
share
Share
Sun Pharma management rejig: Aalok Shanghvi gets a bigger role
Aalok, who is currently the Senior-Vice President, Emerging Markets and Global R&D, will have additional responsibility for generic business development.
Aalok, who is currently the Senior-Vice President, Emerging Markets and Global R&D, will have additional responsibility for generic business development.
moneycontrol.com
Like
reply
Reply
share
Share
Sensex rallies 400 pts, Nifty back above 11K; 5 factors driving markets
Another reason for today’s rally could be a short covering in most beaten down stocks. In previous session, 77 stocks among F&O segment saw a short build-up and 76 stocks saw long unwinding
Another reason for today’s rally could be a short covering in most beaten down stocks. In previous session, 77 stocks among F&O segment saw a short build-up and 76 stocks saw long unwinding
moneycontrol.com
Like
reply
Reply
share
Share
BTVI Live on Twitter
“#JustIN Sun Pharma Announces Licencing Agreement With CSIR-I”
“#JustIN Sun Pharma Announces Licencing Agreement With CSIR-I”
t.co
#JustIN Sun Pharma Announces Licencing Agreement With CSIR-I https://t.co/HzMypVLLSN
Like
reply
Reply
share
Share
Brokerages mixed on Sun Pharma post Q1 results; stock down 5%
The healthcare major’s June quarter earnings beat analyst expectations on all parameters, with profit growing more than 31 percent on growth in India and US businesses.
The healthcare major’s June quarter earnings beat analyst expectations on all parameters, with profit growing more than 31 percent on growth in India and US businesses.
moneycontrol.com
Like
reply
Reply
share
Share
BUY SUNPHARMA FUTURE@409 SL 2 TARGET 418-423
1
reply
Reply (3)
share
Share
Latest replies
NEW HIGH 414.30
NEW HIGH 417
RS 8800 PROFIT TILL NOW
SUNPHARMA NSE CASH BUY ABOVE 445 FOR TARGET 450 - 455
CMP 439
FUT TRADERS BUY ABOVE 442, CMP 435, TARGET 447 - 452
Like
reply
Reply
share
Share
💠💠 Sun Pharmaceutical Industries on Tuesday reported a consolidated net profit of ₹1,387.48 crore for the quarter ended June 30, 2019.
The company had posted a profit of ₹1,057.29 crore for the corresponding period of the previous fiscal, Sun Pharma said in a filing to BSE.
To...
Read more...
Like
reply
Reply
share
Share
Market highlights: Here are 10 key developments of the day
Investors remained anxious as to see when and if the government will announce its decision on tax surcharge on FPIs and measures to stem the weakening economy
Investors remained anxious as to see when and if the government will announce its decision on tax surcharge on FPIs and measures to stem the weakening economy
moneycontrol.com
Like
reply
Reply
share
Share
# SUNPHARMA OVERVIEW
Like
reply
Reply
share
Share
Sun Pharma Q1 beats estimates, profit jumps 31% driven by India, US biz
Profit increased to Rs 1,387.5 crore in Q1, from Rs 1,057.3 crore in same period last year.
Profit increased to Rs 1,387.5 crore in Q1, from Rs 1,057.3 crore in same period last year.
moneycontrol.com
Like
reply
Reply
share
Share
# SUNPHARMA OVERVIEW
Like
reply
Reply
share
Share
Buy sun pharma @436
Like
reply
Reply (1)
share
Share
Latest replies
444...still hold if you can..sl is 420...it can give good return
Sunpharma
1
reply
Reply (2)
share
Share
Latest replies
Target 486?
Monthly?
BUY SUN PHARMA FUT 423 SL 419 TGT 427/432/440/444
Like
reply
Reply
share
Share
Stocks in the news: RIL, Tata Motors, ONGC, BHEL, BPCL, Sintex Plastics, Varroc Engg, Oil India
Tata Motors | Alembic | Bosch | National Aluminium Company | Unichem Laboratories | ONGC | BHEL | BPCL and Sintex Plastics are among stocks, which are in news today.
Tata Motors | Alembic | Bosch | National Aluminium Company | Unichem Laboratories | ONGC | BHEL | BPCL and Sintex Plastics are among stocks, which are in news today.
www.moneycontrol.com
Like
reply
Reply
share
Share
08-08-2019
Profit Rs- *213,897in* Equity Future Calls (Profit loss Count one lot)
Tata steel = *5305/-*
UPL = *13770/-*
Reliance = *20400/-*
Indusind bank = *12280/-*
Eichermotor = *10000/-*
Tata motors = *3000/-*
DHFL = *8000/-*
Vedl = *2850/-*
Zeel = *5265/-*
Ibul...
Read more...
Like
reply
Reply
share
Share
- NewsBotYesterday 3:33 PMThese 12 Nifty stocks trading at discount to 5-yr avg P/E; time to buy?MoneycontrolNewsBotAug 19 10:58 PMAn evening walk down D-St: Sensex, Nifty erase most gains to end marginally higherMoneycontrolNewsBotAug 19 9:33 PMBuy these 15 handpicked stocks for 11-44% return in next one yearMoneycontrolNewsBotAug 19 4:23 PMSun Pharma climbs 5% after USFDA classifies Halol plant as 'No Action Indicated'MoneycontrolNewsBotAug 19 12:33 AMTrade Setup for Monday: Top 15 things to know before Opening BellMoneycontrolNewsBotAug 17 2:23 AMSun Pharma enters pact with China Medical Systems to commercialise 7 generic productsmoneycontrol.comNewsBotAug 16 9:48 PMHold Sun Pharmaceutical Industries; target of Rs 470: ICICI Directmoneycontrol.comNewsBotAug 16 4:43 PMChart Check: Where are Sun Pharma, Glenmark headed after a 5-10% fall in two days?moneycontrol.comNewsBotAug 16 4:13 PMChart Check: Where is Sun Pharma, Glenmark headed after 5-10% fall in two days?moneycontrol.comNewsBotAug 16 4:03 PMChart Check: Where is Sun Pharma, Glenmark headed after Wednesday’s 4-8% fall?www.moneycontrol.com
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.